id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-320902-1hfxju5f	Filocamo, Giovanni	Use of anakinra in severe COVID-19: a case report	2020-05-11		.txt	text/plain	1442	51	34	While the former accounts for 80% of cases, severe disease with acute respiratory distress syndrome (ARDS) and critical disease with respiratory failure and/or multiple organ dysfunction are diagnosed in 15-30% and 5% of COVID-19 patients, respectively (1). To date, May the 5th 2020, 12 clinical trials on anakinra in COVID-19 patients are registered on ClinicalTrials.gov, 7 of them recruiting patients.	cache/cord-320902-1hfxju5f.txt	txt/cord-320902-1hfxju5f.txt
